AZD5363, a catalytic pan-Akt inhibitor, in Akt1 E17K mutation positive advanced solid tumors
Year: 2015
Type: conference-paper
Study design: Clinical Trial
Authors: David M. Hyman, Lillian M. Smyth, Philippe L. Bédard, Amit M. Oza, Emma Dean, Anne Armstrong, João Paulo da Silveira Nogueira Lima, Hideaki Bando, Peter Kabos, Jose Alejandro Pérez Fidalgo, Kathleen N. Moore, Shannon N. Westin, Benoît You, Sarat Chandarlapaty, Leila Alland, Helen Ambrose, Andrew Foxley, Justin P.O. Lindemann, Martin Pass, Paul Rugman, Shaista Salim, Gaia Schiavon, Kenji Tamura, José Baselga, Udai Banerji
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2576460558